I would agree with you. This approval made ACUR look good! What a dud! But like I said when I sold ACUR Profit is Profit! OK I said it! What happened to that $3 target. Hit $2 in PM!
Today’s action in FCSC is fully consistent with what I predicted three weeks ago. The company’s newfangled product has no chance of capturing more than a minuscule share of the market for aesthetic medicine.
Market Data 
Markets 
AI
